Aurobindo Pharma denies stake in Jagathi Publications

22 Aug 2011 Evaluate

Aurobindo Pharma has clarified that the company or any of its subsidiaries do not have investments in Jagathi Publications or in any of its Associate Companies.

Recently, HDFC Trustee Company picked 5.01% stake in Aurobindo Pharma for its different funds. The trustee company purchased 145,93,640 equity shares amounting to 5.01% of the paid up equity share capital. The purchase was carried out in open market and the company did not provide the value of the acquisition.

Aurobindo Pharma headquartered at Hyderabad, India, manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company reported a net loss of Rs 101.58 crore for the quarter ended June 30, 2011 as compared to net profit of Rs 63.34 crore for the quarter ended June 30, 2010. The company’s total income registered growth of 18.77% at Rs 1031.87 crore for the June quarter of FY12  from Rs 868.81 crore for the June quarter of the previous Fiscal.

Aurobindo Pharma Share Price

1240.70 -14.70 (-1.17%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.